Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Vikas Aggarwal(University of Michigan), Vallerie V. McLaughlin(University of Michigan), Ehtisham Mahmud(Cardiovascular Institute of the South), Frances Rogers, Deepa Gopalan(Addenbrooke's Hospital), Jay Giri(Hospital of the University of Pennsylvania), Hiromi Matsubara(Okayama Medical Center), Michael M. Madani(University of California San Diego), Kenneth Rosenfield(Massachusetts General Hospital), Scott Visovatti(Cardiovascular Research Center)
Cited by 35
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Risk stratification and medical therapy of pulmonary arterial hypertension
|European Respiratory Journal|2018|834
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
|Circulation|2018|712
Updated Treatment Algorithm of Pulmonary Arterial Hypertension
|Journal of the American College of Cardiology|2013|663